PharmaEssentia Corporation 6446.TWO Stock
PharmaEssentia Corporation Price Chart
PharmaEssentia Corporation 6446.TWO Financial and Trading Overview
| PharmaEssentia Corporation stock price | 320.5 TWD |
| Previous Close | 337 TWD |
| Open | 337 TWD |
| Bid | 336.5 TWD x 0 |
| Ask | 337 TWD x 0 |
| Day's Range | 334 - 340 TWD |
| 52 Week Range | 315 - 622 TWD |
| Volume | 1.51M TWD |
| Avg. Volume | 2.74M TWD |
| Market Cap | 113.74B TWD |
| Beta (5Y Monthly) | 0.514726 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 440.2 TWD |
6446.TWO Valuation Measures
| Enterprise Value | 93.6B TWD |
| Trailing P/E | N/A |
| Forward P/E | 35.927505 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 32.330566 |
| Price/Book (mrq) | 8.445269 |
| Enterprise Value/Revenue | 26.607 |
| Enterprise Value/EBITDA | -44.602 |
Trading Information
PharmaEssentia Corporation Stock Price History
| Beta (5Y Monthly) | 0.514726 |
| 52-Week Change | -29.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 622 TWD |
| 52 Week Low | 315 TWD |
| 50-Day Moving Average | 368.07 TWD |
| 200-Day Moving Average | 468.41 TWD |
6446.TWO Share Statistics
| Avg. Volume (3 month) | 2.74M TWD |
| Avg. Daily Volume (10-Days) | 2.47M TWD |
| Shares Outstanding | 337.5M |
| Float | 284.56M |
| Short Ratio | N/A |
| % Held by Insiders | 18.93% |
| % Held by Institutions | 12.76% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -44.61% |
| Operating Margin (ttm) | -62.44% |
| Gross Margin | 76.55% |
| EBITDA Margin | -59.65% |
Management Effectiveness
| Return on Assets (ttm) | -12.41% |
| Return on Equity (ttm) | -19.41% |
Income Statement
| Revenue (ttm) | 3.52B TWD |
| Revenue Per Share (ttm) | 12.1 TWD |
| Quarterly Revenue Growth (yoy) | 252.59% |
| Gross Profit (ttm) | 2.07B TWD |
| EBITDA | -2098624000 TWD |
| Net Income Avi to Common (ttm) | -1569492992 TWD |
| Diluted EPS (ttm) | -5.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.97B TWD |
| Total Cash Per Share (mrq) | 39.33 TWD |
| Total Debt (mrq) | 2.98B TWD |
| Total Debt/Equity (mrq) | 24.49 TWD |
| Current Ratio (mrq) | 3.69 |
| Book Value Per Share (mrq) | 39.904 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1435782016 TWD |
| Levered Free Cash Flow (ttm) | -1371231488 TWD |
Profile of PharmaEssentia Corporation
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 3, Park Street |
| ZIP | 115 |
| Phone | 886 2 2655 7688 |
| Website | https://www.pharmaessentia.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include BESREMi (ropeginterferon alfa-2b) that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, primary myelofibrosis, polycythemia vera, and essential thrombocythemia. The company licensed to develop Oraxol for the treatment of breast, gastric, gastro-esophageal, and esophageal cancer; and KX01 for the treatment of psoriasis. In addition, it focuses on the drug research and development programs in the areas of hematology, infectious disease, oncology, and dermatology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.
Q&A For PharmaEssentia Corporation Stock
What is a current 6446.TWO stock price?
PharmaEssentia Corporation 6446.TWO stock price today per share is 320.5 TWD.
How to purchase PharmaEssentia Corporation stock?
You can buy 6446.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PharmaEssentia Corporation?
The stock symbol or ticker of PharmaEssentia Corporation is 6446.TWO.
Which industry does the PharmaEssentia Corporation company belong to?
The PharmaEssentia Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does PharmaEssentia Corporation have in circulation?
The max supply of PharmaEssentia Corporation shares is 330.82M.
What is PharmaEssentia Corporation Price to Earnings Ratio (PE Ratio)?
PharmaEssentia Corporation PE Ratio is 0.00000000 now.
What was PharmaEssentia Corporation earnings per share over the trailing 12 months (TTM)?
PharmaEssentia Corporation EPS is 0 TWD over the trailing 12 months.
Which sector does the PharmaEssentia Corporation company belong to?
The PharmaEssentia Corporation sector is Healthcare.